CVR 29600937Private limited company (ApS)Forskning og eksperimentel udvikling indenfor bioteknologi (721100)Agern Alle 24, 2970 HørsholmFounded 24 May 2006
Compare withsimilar companiesanother companyits industry
DRUGMODE ApS
The newest trades with a company on a side are on the latest property trades.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Cite as: DRUGMODE ApS, https://dandex.ai/company/29600937/drugmode. Source: Dandex, from CVR, read 22 Nov 2026.
Dandex is Danish Company Data. Connect it once and ask about DRUGMODE ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Dandex has an MCP server at https://dandex.ai/mcp and a REST API at https://dandex.ai/api/v1.
Set up DandexEmployees
0
CVR, 2011
Gross profit
-494.3K
DKK, annual report 2014
Result
-4.1M
DKK, annual report 2014
Equity
-75.6M
DKK, annual report 2014
MC2 Therapeutics A/SCVR 29526346, 90% to under 100% of capital and votes, until 21 Dec 2015
FEY HOLDING ApSCVR 29530777, 5% to under 10% of capital and votes, until 21 Dec 2015
Morten Præstegaarduntil 21 Dec 2015
No current owner is registered.
CVR 295307775% to under 10% of capital and votes18 May 2011 to 21 Dec 2015
CVR 2952634690% to under 100% of capital and votes18 May 2011 to 21 Dec 2015
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
2011, annual: 0 employees, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| Employees | 10 | 21 | 18 | 15 | No count | No count | No count | No count | 0 |
| FTE | 3 | 12 | 18 | 17 | 16 | 18 | 17 | 14 | 1 |
| Series | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest 2011, published 18 Jul 2013.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2014, DKK: Gross profit -494.3K, Operating profit -494.3K, Result for the year -4.1M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2014, DKK: Total assets 145.2K, Equity -75.6M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|
| Gross profit | Not reported | Not reported | -2,492 | -1,048 | -494 |
| Operating profit | Not reported | Not reported | -2,492 | -1,048 | -494 |
| Result for the year | Not reported | Not reported | -5,436 | -4,580 | -4,148 |
| Equity | Not reported | Not reported | -66,858 | -71,438 | -75,587 |
| Total assets | Not reported | Not reported | 432 | 217 | 145 |
| Employees (average) | Not reported | Not reported | 0 | 0 | 0 |
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseDebt conversionPaid in 82,345,272 | None | 82,345,272 | None | 18,781,001 | |
| IncreaseCashPaid in 22,000,000, cash price 1.19, implied value 22,334,365 | 1.19 | 22,000,000 | 22,334,365 | 18,781,000 | |
| IncreaseCash, contribution in kindPaid in 6,249,991, cash price 40.09, implied value 11,261,241 | 40.09 | 6,249,991 | 11,261,241 | 280,899 | |
| FoundingNot read from the announcement | None | None | None | 125,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | Not reported | Not reported | -100% | -100% | -100% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Merger (fusion), as the ceasing company (ophørende selskab)
Merger (fusion), as the continuing company (fortsættende selskab)
Source: CVR, read 22 Nov 2026.
25 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion. Kapitalejerne har i enighed besluttet, at der ikke skal udarbejdes en fusionsplan. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i de deltagende selskaber må antages at være tilstrækkeligt sikrede efter fusionen.
Virksomheden er d. 21.12.2015 opløst ved fusion med CVR-nummer: 29312206 ZADEC ApS.
Vedtægter ændret: 18.12.2015
Kapitalforhøjelse: kr. 1,00, indbetalt ved konvertering af gæld, kurs 8.234.527.237,00.
Kapitalen udgør herefter kr. 18.781.001,00.
CVR-nummer
29600937.
NAVN:
DRUGMODE ApS.
Adresse: c/o MC2 Biotek ApS, Bøge Alle 5, 1., 2970 Hørsholm.
Kommune: Rudersdal.
Ny adresse: c/o MC2 Biotek ApS, Agern Alle 24-26, 2970 Hørsholm
Ny kommune: Rudersdal
Nyt binavn: PRIDE PROTEOMICS ApS.
Selskabet er fusioneret med CVR-NR. 25133072 PRIDE PROTEOMICS A/S, der samtidig er opløst.
Erhvervs- og Selskabsstyrelsen har modtaget
fusionsplan for den påtænkte fusion mellem
CVR-NR. 29600937 DRUGMODE ApS (fortsættende), der tillige driver virksomhed under navnet DRUGMAP ApS.
CVR-NR. 25133072 PRIDE PROTEOMICS A/S (ophørende).
Der er endvidere modtaget erklæring fra
vurderingsmændene om, at kreditorerne i
Direktion:
Udtrådt af direktionen:
Jesper Roested, den 11.04.2011.
Indtrådt i direktionen:
Morten Præstegaard, den 11.04.2011.
Direktion:
Udtrådt af direktionen:
Stephen John Fey, den 31.01.2011.
Indtrådt i direktionen:
Jesper Roested, den 31.01.2011.
Ny adresse:
c/o MC2 Biotek ApS, Bøge Alle 5, 1., 2970 Hørsholm.
Ny kommune:
Rudersdal.
Vedtægter ændret:
26.05.2010.
Bestyrelse:
Udtrådt af bestyrelsen:
Peter Mose Larsen, den 28.05.2008.
Indtrådt i bestyrelsen:
Direktør Mads Jørgen Nøhr Clausen, den 28.05.2008.
Vedtægter ændret:
19.05.2008.
Kapitalforhøjelse kr. 18.500.101,00: kr. 101,00 indbetalt kontant, kurs 3.465.346,53, kr. 18.500.000,00 indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 18.781.000,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Mads Jørgen Nøhr Clausen, den 01.06.2007.
Indtrådt i bestyrelsen:
Jørgen Marcus Nøhr Clausen, den 01.06.2007.
Direktion:
Udtrådt af direktionen:
Peter Mose Larsen, den 07.06.2007.
Indtrådt i direktionen:
Professor Stephen John Fey, den 07.06.2007.
Bestyrelse:
Udtrådt af bestyrelsen:
Jørgen Marcus Nøhr Clausen, den 01.06.2007.
Indtrådt i bestyrelsen:
Mads Jørgen Nøhr Clausen, den 01.06.2007.
Vedtægter ændret:
21.09.2006.
Kapitalforhøjelse kr. 155.899,00: kr. 87.304,00 indbetalt kontant, kurs 4.009,00, kr. 68.595,00 indbetalt i værdier, kurs 4.009,00.
Kapitalen udgør herefter kr. 280.899,00.
Bestyrelse:
Indtrådt i bestyrelsen:
Advokat Jesper Jørn Lange (formand), den 21.09.2006, Jørgen Marcus Nøhr Clausen, den 21.09.2006, Direktør Anette Merete Nøhr Clausen, den 21.09.2006, Centerleder, ass. professor Peter Mose Larsen, den 21.09.2006.
Selskabet tegnes af bestyrelsens formand og en direktør i forening samt af den samlede bestyrelse.
Direktion:
Udtrådt af direktionen:
Steen Sindet-Pedersen, den 19.09.2006.
Indtrådt i direktionen:
Direktør Anette Merete Nøhr Clausen, den 19.09.2006.
Vedtægter ændret:
21.06.2006.
Vedtægter ændret:
21.06.2006.
Nyt navn:
DRUGMODE ApS.
Nyt binavn: DRUGMAP ApS (DRUGMODE ApS).
Stiftelsesdato:
24.05.2006.
Seneste vedtægtsdato:
24.05.2006.
Kapital:
kr. 125.000,00.
Indbetalingsmåde:
kontant kr. 125.000,00 til kurs 100,00.
Stifter:
CVR-NR. 29600767 DRUGMAP HOLDING ApS, Forskerparken 10C, 5230 Odense M, den 24.05.2006.
Direktion:
Centerleder, ass. professor Peter Mose Larsen, den 24.05.2006, Steen Sindet-Pedersen, den 24.05.2006.
Selskabet tegnes af den samlede direktion.
Revision:
CVR-NR. 24213714 DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB, Weidekampsgade 6, 2300 København S, den 24.05.2006.
Første regnskabsår:
24.05.2006 - 31.12.2006.
Regnskabsår:
01.01 - 31.12.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 22 Nov 2026.
What Pro holds for DRUGMODE ApS:
Have Pro? Sign in.
P-number 1012290507Agern Alle 24, 2970 Hørsholm